DNA damage and repair in age-related inflammation

Y Zhao, M Simon, A Seluanov… - Nature Reviews …, 2023 - nature.com
Genomic instability is an important driver of ageing. The accumulation of DNA damage is
believed to contribute to ageing by inducing cell death, senescence and tissue dysfunction …

DNA repair pathways and cisplatin resistance: an intimate relationship

CRR Rocha, MM Silva, A Quinet, JB Cabral-Neto… - Clinics, 2018 - SciELO Brasil
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors.
Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its …

Fisetin is a senotherapeutic that extends health and lifespan

MJ Yousefzadeh, YI Zhu, SJ McGowan, L Angelini… - …, 2018 - thelancet.com
Background Senescence is a tumor suppressor mechanism activated in stressed cells to
prevent replication of damaged DNA. Senescent cells have been demonstrated to play a …

Identification of HSP90 inhibitors as a novel class of senolytics

H Fuhrmann-Stroissnigg, YY Ling, J Zhao… - Nature …, 2017 - nature.com
Aging is the main risk factor for many chronic degenerative diseases and cancer. Increased
senescent cell burden in various tissues is a major contributor to aging and age-related …

PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer

RM Chabanon, G Muirhead, DB Krastev… - The Journal of …, 2019 - Am Soc Clin Investig
The cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway detects
cytosolic DNA to activate innate immune responses. Poly (ADP-ribose) polymerase …

Molecular mechanisms of cisplatin resistance

L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins… - Oncogene, 2012 - nature.com
Platinum-based drugs, and in particular cis-diamminedichloroplatinum (II)(best known as
cisplatin), are employed for the treatment of a wide array of solid malignancies, including …

Homologous recombination in DNA repair and DNA damage tolerance

X Li, WD Heyer - Cell research, 2008 - nature.com
Homologous recombination (HR) comprises a series of interrelated pathways that function in
the repair of DNA double-stranded breaks (DSBs) and interstrand crosslinks (ICLs). In …

[HTML][HTML] DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy

KA Olaussen, A Dunant, P Fouret… - … England Journal of …, 2006 - Mass Medical Soc
Background Adjuvant cisplatin-based chemotherapy improves survival among patients with
completely resected non–small-cell lung cancer, but there is no validated clinical or biologic …

DNA damage response

G Giglia-Mari, A Zotter… - Cold Spring Harbor …, 2011 - cshperspectives.cshlp.org
Structural changes to DNA severely affect its functions, such as replication and transcription,
and play a major role in age-related diseases and cancer. A complicated and entangled …

[PDF][PDF] XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4

DK Douwel, RACM Boonen, DT Long, AA Szypowska… - Molecular cell, 2014 - cell.com
DNA interstrand crosslinks (ICLs), highly toxic lesions that covalently link the Watson and
Crick strands of the double helix, are repaired by a complex, replication-coupled pathway in …